“We are pleased to accomplish this important regulatory milestone. Receiving CE Mark for Provent Therapy will facilitate our international commercialization strategy and allow us to launch this product in selected countries over the next several months,” said Peter Wyles, president and CEO of Ventus Medical. “We intend to introduce Provent Therapy internationally in a systematic way through established distributors, focusing on countries with a high prevalence of obstructive sleep apnea. There is a clear need for therapeutic options other than CPAP, and Provent Therapy represents an attractive new alternative.”
November 21, 2018
Dentsply Sirona Academy Charlotte
The Ritz-Carlton, New Orleans
DoubleTree by Hilton Hotel Houston - Greenway Plaza
No event found!